Indo US Bio-Tech (NSE:INDOUS) Net Margin %: 7.58% (As of Mar. 2026) — 29% Below Median


NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
63 GF Score
Price ₹88.75
GF Value ₹198.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech Net Margin %?

Indo US Bio-Tech NSE:INDOUS -0.27% 63 Net Margin % is 7.58% as of Mar. 2026, which is 29% below its 10-year median of 10.71. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.40 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 250 Agriculture companies, Indo US Bio-Tech ranks better than 83.6% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Indo US Bio-Tech's Net Income for the three months ended in Mar. 2026 was ₹20 Mil. Indo US Bio-Tech's Revenue for the three months ended in Mar. 2026 was ₹260 Mil. Therefore, Indo US Bio-Tech's net margin for the quarter that ended in Mar. 2026 was 7.58%.

The historical rank and industry rank for Indo US Bio-Tech's Net Margin % or its related term are showing as below:

NSE:INDOUS' s Net Margin % Range Over the Past 10 Years
Min: 1.62   Med: 10.71   Max: 15.67
Current: 11.88


NSE:INDOUS's Net Margin % is ranked better than
83.6% of 250 companies
in the Agriculture industry
Industry Median: 4.12 vs NSE:INDOUS: 11.88

Indo US Bio-Tech  (NSE:INDOUS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Indo US Bio-Tech Net Margin % Related Terms


Indo US Bio-Tech Net Margin % Historical Data

* Premium members only.

The historical data trend for Indo US Bio-Tech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Net Margin % Chart

Indo US Bio-Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.11 11.73 11.31 15.67 11.88

Indo US Bio-Tech Quarterly Data
Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.14 15.28 11.19 13.14 7.58

NSE:INDOUS vs CTVA, CF: Net Margin % Comparison

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech Net Margin % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Net Margin % falls into.


NSE:INDOUS
63GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Indo US Bio-Tech's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=131.229/1104.391
=11.88 %

Indo US Bio-Tech's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=19.717/260.247
=7.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 7.58% mean?
Indo US Bio-Tech (NSE:INDOUS) has a Net Margin % of 7.58% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Indo US Bio-Tech and its competitors. This is 29% below median its historical median of 10.71. Over the past decade, Indo US Bio-Tech's Net Margin % has ranged from 1.62 to 15.67. According to the industry distribution chart, Indo US Bio-Tech ranks #41 out of 250 companies in the Agriculture industry, placing it in the top 16.4%.
Is Indo US Bio-Tech's Net Margin % too high?
Indo US Bio-Tech's current Net Margin % of 7.58% is 29% below median its 10-year median of 10.71. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 15.67. The Agriculture industry median Net Margin % is 4.12. Indo US Bio-Tech's value of 7.58% is 84% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #41 out of 250 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Net Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #41 out of 250 companies for Net Margin %. This places Indo US Bio-Tech in the top 16% of its industry — outperforming the majority of peers. The industry median Net Margin % is 4.12. Indo US Bio-Tech's value of 7.58% is 84% above this benchmark. Historically, Indo US Bio-Tech's own Net Margin % has ranged from 1.62 to 15.67 over the past decade. While the company's 10-year median is 10.71 vs. the industry median of 4.12, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for an Agriculture company?
The median Net Margin % among Agriculture companies is 4.12, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Net Margin % of 7.58% is 84% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Net Margin % is 4.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Net Margin % is 7.58%, which is 29% below median its own 10-year median of 10.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.40, compared to a current price of ₹88.75 — trading 55.3% below its estimated fair value. The current Net Margin % is 7.58%, which is 29% below median its 10-year median of 10.71 and 84% above the Agriculture industry median of 4.12. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Net Margin % is 7.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹88.75 is trading 55.3% below its estimated GF Value™ of ₹198.40. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • Net Margin %: 7.58% (29% below median its 10-year median of 10.71)
  • GF Value™: ₹198.40 vs. price of ₹88.75 (55.3% below fair value)
  • GF Score™: 63/100 with 5 warning signs
  • Industry Position: 84% above the Agriculture median (#41 of 250)

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score

Get the complete analysis for NSE:INDOUS

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹88.75
Price
₹198.40
GF Value